Table of Content

1 Study Coverage
1.1 Human Rabies Immunoglobulin (IM) Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type
1.4.2 ERIG
1.4.3 HRIG
1.3 Market by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts 2016-2027
2.2 Global Human Rabies Immunoglobulin (IM) Revenue Estimates and Forecasts 2016-2027
2.3 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Human Rabies Immunoglobulin (IM) Regions by Sales
2.4.1 Global Top Human Rabies Immunoglobulin (IM) Regions by Sales (2016-2021)
2.4.2 Global Top Human Rabies Immunoglobulin (IM) Regions by Sales (2022-2027)
2.5 Global Top Human Rabies Immunoglobulin (IM) Regions by Revenue
2.5.1 Global Top Human Rabies Immunoglobulin (IM) Regions by Revenue (2016-2021)
2.5.2 Global Top Human Rabies Immunoglobulin (IM) Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers
3.1.1 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Sales (2016-2021)
3.1.2 Global Top Human Rabies Immunoglobulin (IM) Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Human Rabies Immunoglobulin (IM) Sales in 2020
3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers
3.2.1 Global Top Human Rabies Immunoglobulin (IM) Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Human Rabies Immunoglobulin (IM) Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Immunoglobulin (IM) Revenue in 2020
3.3 Global Human Rabies Immunoglobulin (IM) Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Rabies Immunoglobulin (IM) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Human Rabies Immunoglobulin (IM) Sales by Type
4.1.1 Global Human Rabies Immunoglobulin (IM) Historical Sales by Type (2016-2021)
4.1.2 Global Human Rabies Immunoglobulin (IM) Forecasted Sales by Type (2022-2027)
4.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
4.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type
4.2.1 Global Human Rabies Immunoglobulin (IM) Historical Revenue by Type (2016-2021)
4.2.2 Global Human Rabies Immunoglobulin (IM) Forecasted Revenue by Type (2022-2027)
4.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
4.3 Global Human Rabies Immunoglobulin (IM) Price by Type
4.3.1 Global Human Rabies Immunoglobulin (IM) Price by Type (2016-2021)
4.3.2 Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Human Rabies Immunoglobulin (IM) Sales by Application
5.1.1 Global Human Rabies Immunoglobulin (IM) Historical Sales by Application (2016-2021)
5.1.2 Global Human Rabies Immunoglobulin (IM) Forecasted Sales by Application (2022-2027)
5.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
5.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application
5.2.1 Global Human Rabies Immunoglobulin (IM) Historical Revenue by Application (2016-2021)
5.2.2 Global Human Rabies Immunoglobulin (IM) Forecasted Revenue by Application (2022-2027)
5.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
5.3 Global Human Rabies Immunoglobulin (IM) Price by Application
5.3.1 Global Human Rabies Immunoglobulin (IM) Price by Application (2016-2021)
5.3.2 Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2022-2027)

6 North America
6.1 North America Human Rabies Immunoglobulin (IM) Market Size by Type
6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2027)
6.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2027)
6.2 North America Human Rabies Immunoglobulin (IM) Market Size by Application
6.2.1 North America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2027)
6.2.2 North America Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2027)
6.3 North America Human Rabies Immunoglobulin (IM) Market Size by Country
6.3.1 North America Human Rabies Immunoglobulin (IM) Sales by Country (2016-2027)
6.3.2 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Rabies Immunoglobulin (IM) Market Size by Type
7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2017-2027)
7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2017-2027)
7.2 Europe Human Rabies Immunoglobulin (IM) Market Size by Application
7.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2017-2027)
7.2.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2017-2027)
7.3 Europe Human Rabies Immunoglobulin (IM) Market Size by Country
7.3.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2017-2027)
7.3.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Type
8.1.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2018-2027)
8.1.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Type (2018-2027)
8.2 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Application
8.2.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2018-2027)
8.2.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Application (2018-2027)
8.3 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Region
8.3.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2018-2027)
8.3.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Rabies Immunoglobulin (IM) Market Size by Type
9.1.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2019-2027)
9.1.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Type (2019-2027)
9.2 Latin America Human Rabies Immunoglobulin (IM) Market Size by Application
9.2.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2019-2027)
9.2.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Application (2019-2027)
9.3 Latin America Human Rabies Immunoglobulin (IM) Market Size by Country
9.3.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2019-2027)
9.3.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Type
6.1.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2016-2027)
6.1.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2027)
6.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Application
6.2.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2016-2027)
6.2.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2027)
6.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Country
6.3.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2016-2027)
6.3.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Description
11.1.5 CSL Behring Related Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Description
11.2.5 Grifols Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Description
11.3.5 Sanofi Related Developments
11.4 Sichuan Yuanda Shuyang
11.4.1 Sichuan Yuanda Shuyang Corporation Information
11.4.2 Sichuan Yuanda Shuyang Overview
11.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Description
11.4.5 Sichuan Yuanda Shuyang Related Developments
11.5 CNBG
11.5.1 CNBG Corporation Information
11.5.2 CNBG Overview
11.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Description
11.5.5 CNBG Related Developments
11.6 Kamada
11.6.1 Kamada Corporation Information
11.6.2 Kamada Overview
11.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Description
11.6.5 Kamada Related Developments
11.7 CBPO
11.7.1 CBPO Corporation Information
11.7.2 CBPO Overview
11.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 CBPO Human Rabies Immunoglobulin (IM) Product Description
11.7.5 CBPO Related Developments
11.8 Shuanglin Bio
11.8.1 Shuanglin Bio Corporation Information
11.8.2 Shuanglin Bio Overview
11.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Description
11.8.5 Shuanglin Bio Related Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Corporation Information
11.9.2 Weiguang Bio Overview
11.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Description
11.9.5 Weiguang Bio Related Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Corporation Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Description
11.10.5 Shanghai RAAS Related Developments
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Description
11.1.5 CSL Behring Related Developments
11.12 VINS
11.12.1 VINS Corporation Information
11.12.2 VINS Overview
11.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 VINS Product Description
11.12.5 VINS Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Human Rabies Immunoglobulin (IM) Value Chain Analysis
12.2 Human Rabies Immunoglobulin (IM) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Rabies Immunoglobulin (IM) Production Mode & Process
12.4 Human Rabies Immunoglobulin (IM) Sales and Marketing
12.4.1 Human Rabies Immunoglobulin (IM) Sales Channels
12.4.2 Human Rabies Immunoglobulin (IM) Distributors
12.5 Human Rabies Immunoglobulin (IM) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Rabies Immunoglobulin (IM) Industry Trends
13.2 Human Rabies Immunoglobulin (IM) Market Drivers
13.3 Human Rabies Immunoglobulin (IM) Market Challenges
13.4 Human Rabies Immunoglobulin (IM) Market Restraints

14 Key Findings in The Global Human Rabies Immunoglobulin (IM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ERIG
Table 3. Major Manufacturers of HRIG
Table 4. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Human Rabies Immunoglobulin (IM) Sales by Region (2016-2021) & (K Units)
Table 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales by Region (2016-2021) & (K Units)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2022-2027)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2016-2021)
Table 12. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2022-2027)
Table 14. Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers (2016-2021)
Table 16. Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2016-2021)
Table 18. Human Rabies Immunoglobulin (IM) Price by Manufacturers 2016-2021 (USD/Unit)
Table 19. Global Human Rabies Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2020)
Table 21. Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Rabies Immunoglobulin (IM) Product Offered
Table 23. Date of Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 26. Global Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 27. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2016-2021)
Table 28. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2022-2027)
Table 29. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2016-2021)
Table 32. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2022-2027)
Table 33. Human Rabies Immunoglobulin (IM) Price by Type (2016-2021) & (USD/Unit)
Table 34. Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 36. Global Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 37. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2016-2021)
Table 38. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2022-2027)
Table 39. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2016-2021)
Table 42. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2022-2027)
Table 43. Human Rabies Immunoglobulin (IM) Price by Application (2016-2021) & (USD/Unit)
Table 44. Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2022-2027) & (USD/Unit)
Table 45. North America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 46. North America Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 47. North America Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 50. North America Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 51. North America Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 54. North America Human Rabies Immunoglobulin (IM) Sales by Country (2022-2027) & (K Units)
Table 55. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 58. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 59. Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 62. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 63. Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 66. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2022-2027) & (K Units)
Table 67. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2022-2027) & (US$ Million)
Table 105. CSL Behring Corporation Information
Table 106. CSL Behring Description and Major Businesses
Table 107. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 109. CSL Behring Recent Developments
Table 110. Grifols Corporation Information
Table 111. Grifols Description and Major Businesses
Table 112. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Grifols Human Rabies Immunoglobulin (IM) Product
Table 114. Grifols Recent Developments
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 119. Sanofi Recent Developments
Table 120. Sichuan Yuanda Shuyang Corporation Information
Table 121. Sichuan Yuanda Shuyang Description and Major Businesses
Table 122. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 124. Sichuan Yuanda Shuyang Recent Developments
Table 125. CNBG Corporation Information
Table 126. CNBG Description and Major Businesses
Table 127. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. CNBG Human Rabies Immunoglobulin (IM) Product
Table 129. CNBG Recent Developments
Table 130. Kamada Corporation Information
Table 131. Kamada Description and Major Businesses
Table 132. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Kamada Human Rabies Immunoglobulin (IM) Product
Table 134. Kamada Recent Developments
Table 135. CBPO Corporation Information
Table 136. CBPO Description and Major Businesses
Table 137. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. CBPO Human Rabies Immunoglobulin (IM) Product
Table 139. CBPO Recent Developments
Table 140. Shuanglin Bio Corporation Information
Table 141. Shuanglin Bio Description and Major Businesses
Table 142. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 144. Shuanglin Bio Recent Developments
Table 145. Weiguang Bio Corporation Information
Table 146. Weiguang Bio Description and Major Businesses
Table 147. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 148. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 149. Weiguang Bio Recent Developments
Table 150. Shanghai RAAS Corporation Information
Table 151. Shanghai RAAS Description and Major Businesses
Table 152. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 153. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 154. Shanghai RAAS Recent Developments
Table 155. Bharat Serum Corporation Information
Table 156. Bharat Serum Description and Major Businesses
Table 157. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 159. Bharat Serum Recent Developments
Table 160. VINS Corporation Information
Table 161. VINS Description and Major Businesses
Table 162. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. VINS Human Rabies Immunoglobulin (IM) Product
Table 164. VINS Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Human Rabies Immunoglobulin (IM) Distributors List
Table 168. Human Rabies Immunoglobulin (IM) Customers List
Table 169. Human Rabies Immunoglobulin (IM) Market Trends
Table 170. Human Rabies Immunoglobulin (IM) Market Drivers
Table 171. Human Rabies Immunoglobulin (IM) Market Challenges
Table 172. Human Rabies Immunoglobulin (IM) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Market Share by Type in 2020 & 2027
Figure 3. ERIG Product Picture
Figure 4. HRIG Product Picture
Figure 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2020 & 2027
Figure 6. Category II Exposure
Figure 7. Category III Exposure
Figure 8. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 9. Global Human Rabies Immunoglobulin (IM) Sales 2016-2027 (K Units)
Figure 10. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Rabies Immunoglobulin (IM) Revenue 2016-2027 (US$ Million)
Figure 12. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Figure 14. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2022-2027)
Figure 15. North America Human Rabies Immunoglobulin (IM) Sales YoY (2016-2027) & (K Units)
Figure 16. North America Human Rabies Immunoglobulin (IM) Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Human Rabies Immunoglobulin (IM) Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Human Rabies Immunoglobulin (IM) Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Human Rabies Immunoglobulin (IM) Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Human Rabies Immunoglobulin (IM) Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Human Rabies Immunoglobulin (IM) Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Human Rabies Immunoglobulin (IM) Revenue in 2020
Figure 27. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 29. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 30. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 31. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 32. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 33. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 34. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 35. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 36. North America Human Rabies Immunoglobulin (IM) Sales Share by Country (2016-2027)
Figure 37. North America Human Rabies Immunoglobulin (IM) Revenue Share by Country (2016-2027)
Figure 38. U.S. Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 41. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 42. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 43. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 44. Europe Human Rabies Immunoglobulin (IM) Sales Share by Country (2016-2027)
Figure 45. Europe Human Rabies Immunoglobulin (IM) Revenue Share by Country (2016-2027)
Figure 46. Germany Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 47. France Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Share by Region (2016-2027)
Figure 57. China Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 60. India Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 66. Philippines Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 68. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 70. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Human Rabies Immunoglobulin (IM) Sales Share by Country (2016-2027)
Figure 72. Latin America Human Rabies Immunoglobulin (IM) Revenue Share by Country (2016-2027)
Figure 73. Mexico Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Share by Country (2016-2027)
Figure 82. Turkey Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 84. U.A.E Human Rabies Immunoglobulin (IM) Revenue (2016-2027) & (US$ Million)
Figure 85. Human Rabies Immunoglobulin (IM) Value Chain
Figure 86. Human Rabies Immunoglobulin (IM) Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed